| A second generation human haplotype map of over 3.1 million SNPs International HapMap Consortium Nature 449 (7164), 851, 2007 | 9707* | 2007 |
| The international HapMap project RA Gibbs, JW Belmont, P Hardenbol, TD Willis, FL Yu, HM Yang, ... Nature Publishing Group, 2003 | 6627 | 2003 |
| Genome-wide detection and characterization of positive selection in human populations PC Sabeti, P Varilly, B Fry, J Lohmueller, E Hostetter, C Cotsapas, X Xie, ... Nature 449 (7164), 913-918, 2007 | 2473 | 2007 |
| Informed consent, parental permission, and assent in pediatric practice P Permission Pediatrics 95 (2), 1995 | 1450* | 1995 |
| A haplotype map of the human genome D Altshuler Nature 437, 1299-1320, 2005 | 1233 | 2005 |
| Development of a large‐scale de‐identified DNA biobank to enable personalized medicine DM Roden, JM Pulley, MA Basford, GR Bernard, EW Clayton, JR Balser, ... Clinical Pharmacology & Therapeutics 84 (3), 362-369, 2008 | 1140 | 2008 |
| Managing incidental findings in human subjects research: analysis and recommendations SM Wolf, FP Lawrenz, CA Nelson, JP Kahn, MK Cho, EW Clayton, ... Journal of Law, Medicine & Ethics 36 (2), 219-248, 2008 | 904 | 2008 |
| Factors that prompted families to file medical malpractice claims following perinatal injuries GB Hickson, EW Clayton, PB Githens, FA Sloan Jama 267 (10), 1359-1363, 1992 | 700 | 1992 |
| Obstetricians' prior malpractice experience and patients' satisfaction with care GB Hickson, EW Clayton, SS Entman, CS Miller, PB Githens, ... Jama 272 (20), 1583-1587, 1994 | 627 | 1994 |
| Guidelines on forgoing life-sustaining medical treatment. A Kohrman, EW Clayton Pediatrics 93 (3), 532-536, 1994 | 519* | 1994 |
| Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility T He journal of Clinical Oncology 14 (5), 1730-1736, 1996 | 482 | 1996 |
| Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project JM Pulley, JC Denny, JF Peterson, GR Bernard, CL Vnencak‐Jones, ... Clinical Pharmacology & Therapeutics 92 (1), 87-95, 2012 | 465 | 2012 |
| Return of genomic results to research participants: the floor, the ceiling, and the choices in between GP Jarvik, LM Amendola, JS Berg, K Brothers, EW Clayton, W Chung, ... The American Journal of Human Genetics 94 (6), 818-826, 2014 | 457 | 2014 |
| Ethical, legal, and social implications of genomic medicine EW Clayton New England Journal of Medicine 349 (6), 562-569, 2003 | 437 | 2003 |
| Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness EW Clayton Jama 313 (11), 1101-1102, 2015 | 431 | 2015 |
| Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group RR Fabsitz, A McGuire, RR Sharp, M Puggal, LM Beskow, LG Biesecker, ... Circulation: Cardiovascular Genetics 3 (6), 574-580, 2010 | 399 | 2010 |
| Informed consent for genetic research on stored tissue samples EW Clayton, KK Steinberg, MJ Khoury, E Thomson, L Andrews, MJE Kahn, ... Jama 274 (22), 1786-1792, 1995 | 384 | 1995 |
| ISSCR guidelines for stem cell research and clinical translation: the 2021 update R Lovell-Badge, E Anthony, RA Barker, T Bubela, AH Brivanlou, ... Stem cell reports 16 (6), 1398-1408, 2021 | 378 | 2021 |
| Privacy in the genomic era M Naveed, E Ayday, EW Clayton, J Fellay, CA Gunter, JP Hubaux, ... ACM Computing Surveys (CSUR) 48 (1), 1-44, 2015 | 369 | 2015 |
| Confronting commercial sexual exploitation and sex trafficking of minors in the United States P Simon, RD Krugman, EW Clayton National Academies Press, 2013 | 368* | 2013 |
